SCHEMBL4902509

SCHEMBL4902509

CCN(c1ccc(Oc2ccccc2)cc1)S(=O)(=O)c1cc(C(=O)O)c(C)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.52
ESR1 P03372 1/20 0.52
POLB P06746 1/20 0.52
APEX1 P27695 1/20 0.52
RECQL P46063 1/20 0.52
ESR2 Q92731 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MCL1 Q07820 4/20 0.49
BCL2L1 Q07817 3/20 0.49
TSHR P16473 1/20 0.47
PTGES O14684 3/20 0.45
ALOX5 P09917 2/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PGR P06401 2/20 0.43
NR3C1 P04150 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906333 0.81 NPC1 (0.48) NSD2ESR1POLBAPEX1RECQL
SCHEMBL4902654 0.81 LMNA (0.61) NSD2ESR1POLBAPEX1RECQL
SCHEMBL4903991 0.78 LMNA (0.54) NSD2ESR1POLBAPEX1RECQL
SCHEMBL11174592 0.75 TSHR (0.51) L3MBTL1TSHRTP53SMN1; SMN2MEN1
SCHEMBL4902498 0.74 ALDH1A1 (0.58) POLBL3MBTL1TP53MAPTSMN1; SMN2
SCHEMBL11174862 0.74 ALDH1A1 (0.62) NSD2ESR1POLBAPEX1RECQL
SCHEMBL11170555 0.74 ESR1 (0.50) NSD2ESR1POLBAPEX1RECQL
SCHEMBL4906440 0.74 LMNA (0.61) ESR1MCL1BCL2L1PTGESALOX5
SCHEMBL4903818 0.74 ESR1 (0.52) ESR1MCL1BCL2L1PTGESALOX5
SCHEMBL4907519 0.73 LMNA (0.54) NSD2ESR1POLBAPEX1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD NSD2 2465/4885ESR1 473/4885POLB 1488/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NSD2 2670/4885ESR1 585/4885POLB 1807/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NSD2 2670/4885ESR1 585/4885POLB 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.